UH3OD035540
Cooperative Agreement
Overview
Grant Description
Preconception and prenatal health impacting factors and child health - childhood obesity and neurodevelopmental impairments have increased in recent decades and are the most prevalent conditions threatening child’s health and well-being.
The consequences of these conditions signify the need to identify modifiable factors to target for upstream prevention.
Emerging evidence suggests that prenatal exposures to psychological distress, substance use, and lifestyle factors during critical windows of fetal development may operate to developmentally program childhood obesity and neurodevelopment (ND).
However, few studies have taken a multiple-exposure approach to understand the individual and joint effects of these exposures.
In Aim 1 we will examine the role of in utero exposure to psychological distress and substance use on child growth, adiposity, obesity, and ND and the extent to which prenatal lifestyle factors and neighborhood factors may mitigate these associations.
Further, while maternal diet and physical activity impact infant growth and adiposity, few studies have assessed mechanistic pathways and little is known about their impact on ND.
We propose the 24-hour movement profile and metabolomics as our specialized measures of lifestyle, and obesity and ND as our specialized outcomes.
The 24-hour movement profile incorporates the interdependent relationships between device-based measures of physical activity and sleep during pregnancy to better inform interventions.
Metabolomics can elucidate mechanistic pathways and will be measured repeatedly on the samples collected according to the ECHO protocol (prenatal blood, cord blood, postnatal child’s blood, and breastmilk).
In Aim 2, we will clarify the joint effects of maternal prenatal dietary patterns and the 24-hour movement and child growth, obesity, and ND, and whether metabolomic signatures prenatally, at birth, and postnatally mediate these associations.
For Aims 1 and 2 we will also examine how associations vary by neighborhood characteristics.
In Aim 3 we will maximize recruitment and retention by implementing evidence-based strategies focused on engaging groups in clinical research and implementing the ECHO cohort protocol applying systematic quality control approaches and best practices.
We propose to contribute to the ECHO program by recruiting a large cohort of 1,800 pregnant women from two medical centers at Kaiser Permanente Northern California serving a large underlying population, the conceiving partner, their resulting child, and to follow all of them at multiple visits after the child is born.
In Aim 4 we will explore the role of preconception maternal and paternal lifestyle factors on infant birth size to identify critical time periods to intervene on to prevent upstream risk factors for childhood obesity and ND.
All members of our research team will have the opportunity to contribute to all aspects of our project and to be involved in the new ECHO phase.
Findings from this study will have important implications for informing interventions, prevention strategies, and policies to ensure optimal health and well-being for all children.
The consequences of these conditions signify the need to identify modifiable factors to target for upstream prevention.
Emerging evidence suggests that prenatal exposures to psychological distress, substance use, and lifestyle factors during critical windows of fetal development may operate to developmentally program childhood obesity and neurodevelopment (ND).
However, few studies have taken a multiple-exposure approach to understand the individual and joint effects of these exposures.
In Aim 1 we will examine the role of in utero exposure to psychological distress and substance use on child growth, adiposity, obesity, and ND and the extent to which prenatal lifestyle factors and neighborhood factors may mitigate these associations.
Further, while maternal diet and physical activity impact infant growth and adiposity, few studies have assessed mechanistic pathways and little is known about their impact on ND.
We propose the 24-hour movement profile and metabolomics as our specialized measures of lifestyle, and obesity and ND as our specialized outcomes.
The 24-hour movement profile incorporates the interdependent relationships between device-based measures of physical activity and sleep during pregnancy to better inform interventions.
Metabolomics can elucidate mechanistic pathways and will be measured repeatedly on the samples collected according to the ECHO protocol (prenatal blood, cord blood, postnatal child’s blood, and breastmilk).
In Aim 2, we will clarify the joint effects of maternal prenatal dietary patterns and the 24-hour movement and child growth, obesity, and ND, and whether metabolomic signatures prenatally, at birth, and postnatally mediate these associations.
For Aims 1 and 2 we will also examine how associations vary by neighborhood characteristics.
In Aim 3 we will maximize recruitment and retention by implementing evidence-based strategies focused on engaging groups in clinical research and implementing the ECHO cohort protocol applying systematic quality control approaches and best practices.
We propose to contribute to the ECHO program by recruiting a large cohort of 1,800 pregnant women from two medical centers at Kaiser Permanente Northern California serving a large underlying population, the conceiving partner, their resulting child, and to follow all of them at multiple visits after the child is born.
In Aim 4 we will explore the role of preconception maternal and paternal lifestyle factors on infant birth size to identify critical time periods to intervene on to prevent upstream risk factors for childhood obesity and ND.
All members of our research team will have the opportunity to contribute to all aspects of our project and to be involved in the new ECHO phase.
Findings from this study will have important implications for informing interventions, prevention strategies, and policies to ensure optimal health and well-being for all children.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Pleasanton,
California
945882761
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 292% from $1,655,214 to $6,495,276.
Kaiser Foundation Hospitals was awarded
Prenatal Exposures Impacting Child Health: Obesity & ND
Cooperative Agreement UH3OD035540
worth $6,495,276
from the National Institute of Allergy and Infectious Diseases in September 2023 with work to be completed primarily in Pleasanton California United States.
The grant
has a duration of 6 years 8 months and
was awarded through assistance program 93.310 Trans-NIH Research Support.
The Cooperative Agreement was awarded through grant opportunity Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3).
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
9/1/23
Start Date
5/31/30
End Date
Funding Split
$6.5M
Federal Obligation
$0.0
Non-Federal Obligation
$6.5M
Total Obligated
Activity Timeline
Transaction History
Modifications to UH3OD035540
Additional Detail
Award ID FAIN
UH3OD035540
SAI Number
UH3OD035540-1316217667
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
P1RTMASB37B5
Awardee CAGE
0ZUC3
Performance District
CA-14
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Modified: 9/5/25